Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...

T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...

While the genesis of typical modern medical technologies focuses on a specific design element or research protocol, for Glucotrack Inc. (NASDAQ: GCTK), the basis of innovation begins at the human ...

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

An assortment of research across clinical and basic science fields was on full display at this year’s UB Resident and Fellow Research Day, which took place May 30 in the Jacobs School of Medicine and ...

Zembrace® SymTouch® (sumatriptan succinate) injection (Zembrace) and Tosymra® (sumatriptan) nasal spray are prescription medicines used to treat acute migraine headaches with or without aura in adults ...

The poster presented at the meeting will be made available on the Glucotrack website following the conference.

Presentation to Highlight Genprex's Study of Reqorsa® Gene Therapy in Combination with Tecentriq® for the Treatment of Exten ...